# Omega-3 Plus Low-Dose Aspirin in Smokers With Stage III Periodontitis

> **NCT07673185** · NA · RECRUITING · sponsor: **Al-Azhar University** · enrollment: 40 (estimated)

## Conditions studied

- Periodontal Disease
- Periodontitis (Stage 3)
- Smoking Behaviors

## Interventions

- **DRUG:** Omega-3 Fatty Acids (EPA plus DHA) plus low dose aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07673185
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-10-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673185, "Omega-3 Plus Low-Dose Aspirin in Smokers With Stage III Periodontitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07673185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*